02:20 PM EST - Immunoprecise Antibodies : Announced the opening of its new 3,200-square-foot state of the art antibody production laboratory at Vancouver Island Technology Park that has been designed in conjunction with Low Hammond Rowe Architects. The addition of this new laboratory: More than doubles the Company's lab footprint; Allows for three times the capacity for hybridoma projects; Architectural and engineering features that enhance workflow and cleanliness; Houses new equipment [High-throughput FACS] to expand services; and Allows for Vivarium expansion up to 10 times the capacity for hybridoma projects. Immunoprecise Antibodies
shares V.IPA are trading up $0.01 at $1.08.
